Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe Covid-19 patients, the Union health ministry has decided not to include the drug in the national treatment protocol for coronavirus patients. In the recent past, the National Task Force on Covid-19 constituted by the Health ministry held its meeting and discussed whether to put Itolizumab drug into the treatment protocol or not.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/39wwqLK
via i